Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination drug containing three active ingredients—acetaminophen, ibuprofen, and oxycodone—used for the management of moderate to severe pain. Acetaminophen is an analgesic and antipyretic that reduces pain and fever by inhibiting prostaglandin synthesis in the central nervous system. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that relieves inflammation, swelling, and pain by inhibiting cyclooxygenase (COX) enzymes involved in prostaglandin production. Oxycodone is an opioid analgesic that acts primarily as an agonist at mu-type opioid receptors in the central nervous system to provide potent pain relief. The combination aims to leverage multiple mechanisms of action for enhanced analgesia while potentially reducing individual drug doses and associated side effects[1][2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on acetaminophen + ibuprofen + oxycodone.